Abstract
Abstract Liver cirrhosis has a higher incidence rate and mortality when complicated with bacterial infections. Concomitant bacterial infections, especially bacterial pneumonia, increase the susceptibility of cirrhotic patients to decompensation, with a higher likelihood of mortality. Bacterial pneumonia is often overlooked in patients with liver cirrhosis, although it can impact the clinical progress and outcomes. Untimely diagnosis and inappropriate antibiotic treatments are associated with poor prognosis and increased mortality. Current understanding of mechanisms and appropriate antibiotic treatments for cirrhosis-related bacterial pneumonia remain inadequate. Herein, we reviewed the epidemiology, clinical characteristics and treatment of pulmonary bacterial infections in cirrhotic patients to provide suggestions for clinical practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
